biotechnology
NVIDIA: EvolutionaryScale Unveils ESM3 Generative AI Model for Protein Design
EvolutionaryScale launches ESM3, an advanced AI model for protein design, leveraging NVIDIA's H100 GPUs to accelerate biological research.
Revolutionizing Antibody Development: AlphaBind Leverages NVIDIA and AWS
AlphaBind, developed by A-Alpha Bio, employs NVIDIA and AWS technologies to enhance antibody-antigen binding predictions, aiming to revolutionize biologics development.
Riot Blockchain Sees Growth in Q1 2020 Despite COVID-19 Disruption
Riot Blockchain Inc., one of the few listed public cryptocurrency mining companies in the United States on Nasdaq, reported financial results for Q1 of 2020, which ended on March 31. The company has seen a small growth in its earnings per share during this quarter. Riot Blockchain previously changed its name from Bioptix in 2017 after shifting its focus from biotechnology to Bitcoin mining. The company’s share price skyrocketed to a $38 high in late 2017, which then fell to $110 after Riot was accused of misleading investors by capitalizing on public interest in blockchain to drive up its share price. These claims have been dismissed on the basis that it was not proven that the company’s name was changed to drive up the share price.
CIA Eyes Blockchain Technology with New Research Lab
US Central Intelligence Agency has rolled an in-house R&D arm dubbed CIA Labs to scale up technological and scientific breakthroughs for future intelligence challenges.